Skip to content

Randomised double blind placebo controlled internet trial of probiotics and ankylosing spondylitis (PAS- trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN36133252
Enrollment
140
Registered
2004-07-07
Start date
2004-09-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing spondylitis Musculoskeletal Diseases Ankylosing Spondylitis

Interventions

Probiotic versus placebo Participants are recruited through the internet (confirmation of diagnosis by general practitioner/rheumatologist) and assessed by weekly internet questionnaires.

Sponsors

University of Wales, Swansea (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of ankylosing spondylitis or other spondyloarthropathy

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 6, 2026